Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.52 USD | +3.35% | +3.02% | -48.82% |
05:05pm | Canaccord Genuity Adjusts Price Target on 10x Genomics to $50 From $65, Maintains Buy Rating | MT |
18/04 | Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.82% | 3.3B | |
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.31% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+0.63% | 1.64B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- UBS Initiates Coverage on 10x Genomics With Neutral Rating, $50 Price Target